Detalhe da pesquisa
1.
Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.
Ann Hematol;
102(5): 1063-1072, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36959484
2.
The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small-cell lung cancer: A systematic review and meta-analysis.
J Clin Pharm Ther;
47(4): 421-429, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34734431
3.
Ethylene Inhibits Anthocyanin Biosynthesis by Repressing the R2R3-MYB Regulator SlAN2-like in Tomato.
Int J Mol Sci;
23(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35887009
4.
TGFß2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance.
Acta Pharmacol Sin;
42(3): 451-459, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32678313
5.
Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.
World J Surg Oncol;
19(1): 133, 2021 Apr 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33888142
6.
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells.
Acta Pharmacol Sin;
38(11): 1512-1520, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28880013
7.
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity.
Discov Oncol;
15(1): 170, 2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38753073
8.
DeepCIP: A multimodal deep learning method for the prediction of internal ribosome entry sites of circRNAs.
Comput Biol Med;
164: 107288, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37542919
9.
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells.
Chin J Nat Med;
21(11): 842-851, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38035939
10.
MT1X is an oncogene and indicates prognosis in ccRCC.
Biosci Rep;
42(10)2022 10 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36149322
11.
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.
Biochem Pharmacol;
197: 114940, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35120895
12.
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies.
Curr Cancer Drug Targets;
22(2): 142-152, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35034596
13.
Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis.
MedComm (2020);
3(3): e152, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35978854
14.
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2.
Acta Pharm Sin B;
12(3): 1240-1253, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35530150
15.
Regulation of CD47 expression by interferon-gamma in cancer cells.
Transl Oncol;
14(9): 101162, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34171557
16.
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Phytomedicine;
80: 153394, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33130472
17.
Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.
Anticancer Agents Med Chem;
20(8): 982-988, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32286950
18.
Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus.
Biochem Pharmacol;
175: 113921, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32201213
19.
Establishment and Characterization of Pemetrexed-resistant NCI-H460/PMT Cells.
Anticancer Agents Med Chem;
19(6): 731-739, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30848214
20.
Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells.
Food Chem Toxicol;
131: 110537, 2019 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31150782